カテゴリー： Market Monitor Global, 世界, 医療/バイオ

非定型ケモカイン受容体3の世界市場見通し2023年-2029年

◆英語タイトル：Atypical Chemokine Receptor 3 Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5700）◆商品コード：MMG23JU5700
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥481,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥625,300見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥721,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Atypical Chemokine Receptor 3 Market 調査レポートは次の情報を含め、グローバルにおけるの非定型ケモカイン受容体3市場規模と予測を収録しています。・世界の非定型ケモカイン受容体3市場：売上、2018年-2023年、2024年-2029年
・世界の非定型ケモカイン受容体3市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非定型ケモカイン受容体3市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CCX-650」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

非定型ケモカイン受容体3のグローバル主要企業は、ChemoCentryx Inc、 Jyant Technologies Inc、 Polyphor Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、非定型ケモカイン受容体3のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の非定型ケモカイン受容体3市場：タイプ別、2018年-2023年、2024年-2029年
世界の非定型ケモカイン受容体3市場：タイプ別市場シェア、2022年
・CCX-650、JT-07、POL-6926、CCX-771、その他

世界の非定型ケモカイン受容体3市場：用途別、2018年-2023年、2024年-2029年
世界の非定型ケモカイン受容体3市場：用途別市場シェア、2022年
・自己免疫疾患、アテローム性動脈硬化症、クローン病、その他

世界の非定型ケモカイン受容体3市場：地域・国別、2018年-2023年、2024年-2029年
世界の非定型ケモカイン受容体3市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における非定型ケモカイン受容体3のグローバル売上、2018年-2023年
・主要企業における非定型ケモカイン受容体3のグローバル売上シェア、2022年
・主要企業における非定型ケモカイン受容体3のグローバル販売量、2018年-2023年
・主要企業における非定型ケモカイン受容体3のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
ChemoCentryx Inc、 Jyant Technologies Inc、 Polyphor Ltd

*************************************************************

・調査・分析レポートの概要
非定型ケモカイン受容体3市場の定義
市場セグメント
世界の非定型ケモカイン受容体3市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非定型ケモカイン受容体3市場規模
世界の非定型ケモカイン受容体3市場規模：2022年 VS 2029年
世界の非定型ケモカイン受容体3市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非定型ケモカイン受容体3の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非定型ケモカイン受容体3製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：CCX-650、JT-07、POL-6926、CCX-771、その他
非定型ケモカイン受容体3のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：自己免疫疾患、アテローム性動脈硬化症、クローン病、その他
非定型ケモカイン受容体3の用途別グローバル売上・予測

・地域別市場分析
地域別非定型ケモカイン受容体3市場規模 2022年と2029年
地域別非定型ケモカイン受容体3売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
ChemoCentryx Inc、 Jyant Technologies Inc、 Polyphor Ltd
...

This report aims to provide a comprehensive presentation of the global market for Atypical Chemokine Receptor 3, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atypical Chemokine Receptor 3. This report contains market size and forecasts of Atypical Chemokine Receptor 3 in global, including the following market information:
Global Atypical Chemokine Receptor 3 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Atypical Chemokine Receptor 3 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Atypical Chemokine Receptor 3 companies in 2022 (%)
The global Atypical Chemokine Receptor 3 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
CCX-650 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Atypical Chemokine Receptor 3 include ChemoCentryx Inc, Jyant Technologies Inc and Polyphor Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atypical Chemokine Receptor 3 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atypical Chemokine Receptor 3 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Atypical Chemokine Receptor 3 Market Segment Percentages, by Type, 2022 (%)
CCX-650
JT-07
POL-6926
CCX-771
Others
Global Atypical Chemokine Receptor 3 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Atypical Chemokine Receptor 3 Market Segment Percentages, by Application, 2022 (%)
Autoimmune Disorders
Atherosclerosis
Crohn’s Disease
Others
Global Atypical Chemokine Receptor 3 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Atypical Chemokine Receptor 3 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atypical Chemokine Receptor 3 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Atypical Chemokine Receptor 3 revenues share in global market, 2022 (%)
Key companies Atypical Chemokine Receptor 3 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Atypical Chemokine Receptor 3 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ChemoCentryx Inc
Jyant Technologies Inc
Polyphor Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Atypical Chemokine Receptor 3, market overview.
Chapter 2: Global Atypical Chemokine Receptor 3 market size in revenue and volume.
Chapter 3: Detailed analysis of Atypical Chemokine Receptor 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atypical Chemokine Receptor 3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Atypical Chemokine Receptor 3 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Atypical Chemokine Receptor 3 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Atypical Chemokine Receptor 3 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Atypical Chemokine Receptor 3 Overall Market Size
2.1 Global Atypical Chemokine Receptor 3 Market Size: 2022 VS 2029
2.2 Global Atypical Chemokine Receptor 3 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Atypical Chemokine Receptor 3 Sales: 2018-2029
3 Company Landscape
3.1 Top Atypical Chemokine Receptor 3 Players in Global Market
3.2 Top Global Atypical Chemokine Receptor 3 Companies Ranked by Revenue
3.3 Global Atypical Chemokine Receptor 3 Revenue by Companies
3.4 Global Atypical Chemokine Receptor 3 Sales by Companies
3.5 Global Atypical Chemokine Receptor 3 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Atypical Chemokine Receptor 3 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Atypical Chemokine Receptor 3 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Atypical Chemokine Receptor 3 Players in Global Market
3.8.1 List of Global Tier 1 Atypical Chemokine Receptor 3 Companies
3.8.2 List of Global Tier 2 and Tier 3 Atypical Chemokine Receptor 3 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Atypical Chemokine Receptor 3 Market Size Markets, 2022 & 2029
4.1.2 CCX-650
4.1.3 JT-07
4.1.4 POL-6926
4.1.5 CCX-771
4.1.6 Others
4.2 By Type – Global Atypical Chemokine Receptor 3 Revenue & Forecasts
4.2.1 By Type – Global Atypical Chemokine Receptor 3 Revenue, 2018-2023
4.2.2 By Type – Global Atypical Chemokine Receptor 3 Revenue, 2024-2029
4.2.3 By Type – Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
4.3 By Type – Global Atypical Chemokine Receptor 3 Sales & Forecasts
4.3.1 By Type – Global Atypical Chemokine Receptor 3 Sales, 2018-2023
4.3.2 By Type – Global Atypical Chemokine Receptor 3 Sales, 2024-2029
4.3.3 By Type – Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
4.4 By Type – Global Atypical Chemokine Receptor 3 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Atypical Chemokine Receptor 3 Market Size, 2022 & 2029
5.1.2 Autoimmune Disorders
5.1.3 Atherosclerosis
5.1.4 Crohn’s Disease
5.1.5 Others
5.2 By Application – Global Atypical Chemokine Receptor 3 Revenue & Forecasts
5.2.1 By Application – Global Atypical Chemokine Receptor 3 Revenue, 2018-2023
5.2.2 By Application – Global Atypical Chemokine Receptor 3 Revenue, 2024-2029
5.2.3 By Application – Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
5.3 By Application – Global Atypical Chemokine Receptor 3 Sales & Forecasts
5.3.1 By Application – Global Atypical Chemokine Receptor 3 Sales, 2018-2023
5.3.2 By Application – Global Atypical Chemokine Receptor 3 Sales, 2024-2029
5.3.3 By Application – Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
5.4 By Application – Global Atypical Chemokine Receptor 3 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Atypical Chemokine Receptor 3 Market Size, 2022 & 2029
6.2 By Region – Global Atypical Chemokine Receptor 3 Revenue & Forecasts
6.2.1 By Region – Global Atypical Chemokine Receptor 3 Revenue, 2018-2023
6.2.2 By Region – Global Atypical Chemokine Receptor 3 Revenue, 2024-2029
6.2.3 By Region – Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
6.3 By Region – Global Atypical Chemokine Receptor 3 Sales & Forecasts
6.3.1 By Region – Global Atypical Chemokine Receptor 3 Sales, 2018-2023
6.3.2 By Region – Global Atypical Chemokine Receptor 3 Sales, 2024-2029
6.3.3 By Region – Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Atypical Chemokine Receptor 3 Revenue, 2018-2029
6.4.2 By Country – North America Atypical Chemokine Receptor 3 Sales, 2018-2029
6.4.3 US Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.4.4 Canada Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.4.5 Mexico Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Atypical Chemokine Receptor 3 Revenue, 2018-2029
6.5.2 By Country – Europe Atypical Chemokine Receptor 3 Sales, 2018-2029
6.5.3 Germany Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.4 France Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.5 U.K. Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.6 Italy Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.7 Russia Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.8 Nordic Countries Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.5.9 Benelux Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Atypical Chemokine Receptor 3 Revenue, 2018-2029
6.6.2 By Region – Asia Atypical Chemokine Receptor 3 Sales, 2018-2029
6.6.3 China Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.6.4 Japan Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.6.5 South Korea Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.6.6 Southeast Asia Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.6.7 India Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Atypical Chemokine Receptor 3 Revenue, 2018-2029
6.7.2 By Country – South America Atypical Chemokine Receptor 3 Sales, 2018-2029
6.7.3 Brazil Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.7.4 Argentina Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Atypical Chemokine Receptor 3 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Atypical Chemokine Receptor 3 Sales, 2018-2029
6.8.3 Turkey Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.8.4 Israel Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.8.5 Saudi Arabia Atypical Chemokine Receptor 3 Market Size, 2018-2029
6.8.6 UAE Atypical Chemokine Receptor 3 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ChemoCentryx Inc
7.1.1 ChemoCentryx Inc Company Summary
7.1.2 ChemoCentryx Inc Business Overview
7.1.3 ChemoCentryx Inc Atypical Chemokine Receptor 3 Major Product Offerings
7.1.4 ChemoCentryx Inc Atypical Chemokine Receptor 3 Sales and Revenue in Global (2018-2023)
7.1.5 ChemoCentryx Inc Key News & Latest Developments
7.2 Jyant Technologies Inc
7.2.1 Jyant Technologies Inc Company Summary
7.2.2 Jyant Technologies Inc Business Overview
7.2.3 Jyant Technologies Inc Atypical Chemokine Receptor 3 Major Product Offerings
7.2.4 Jyant Technologies Inc Atypical Chemokine Receptor 3 Sales and Revenue in Global (2018-2023)
7.2.5 Jyant Technologies Inc Key News & Latest Developments
7.3 Polyphor Ltd
7.3.1 Polyphor Ltd Company Summary
7.3.2 Polyphor Ltd Business Overview
7.3.3 Polyphor Ltd Atypical Chemokine Receptor 3 Major Product Offerings
7.3.4 Polyphor Ltd Atypical Chemokine Receptor 3 Sales and Revenue in Global (2018-2023)
7.3.5 Polyphor Ltd Key News & Latest Developments
8 Global Atypical Chemokine Receptor 3 Production Capacity, Analysis
8.1 Global Atypical Chemokine Receptor 3 Production Capacity, 2018-2029
8.2 Atypical Chemokine Receptor 3 Production Capacity of Key Manufacturers in Global Market
8.3 Global Atypical Chemokine Receptor 3 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Atypical Chemokine Receptor 3 Supply Chain Analysis
10.1 Atypical Chemokine Receptor 3 Industry Value Chain
10.2 Atypical Chemokine Receptor 3 Upstream Market
10.3 Atypical Chemokine Receptor 3 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Atypical Chemokine Receptor 3 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Atypical Chemokine Receptor 3 in Global Market
Table 2. Top Atypical Chemokine Receptor 3 Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Atypical Chemokine Receptor 3 Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Atypical Chemokine Receptor 3 Revenue Share by Companies, 2018-2023
Table 5. Global Atypical Chemokine Receptor 3 Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Atypical Chemokine Receptor 3 Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Atypical Chemokine Receptor 3 Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Atypical Chemokine Receptor 3 Product Type
Table 9. List of Global Tier 1 Atypical Chemokine Receptor 3 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atypical Chemokine Receptor 3 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2018-2023
Table 15. By Type - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2024-2029
Table 16. By Application – Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2018-2023
Table 20. By Application - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2024-2029
Table 21. By Region – Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Atypical Chemokine Receptor 3 Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2018-2023
Table 25. By Region - Global Atypical Chemokine Receptor 3 Sales (K Pcs), 2024-2029
Table 26. By Country - North America Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Atypical Chemokine Receptor 3 Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Atypical Chemokine Receptor 3 Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Atypical Chemokine Receptor 3 Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Atypical Chemokine Receptor 3 Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Atypical Chemokine Receptor 3 Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Atypical Chemokine Receptor 3 Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Atypical Chemokine Receptor 3 Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Atypical Chemokine Receptor 3 Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Sales, (K Pcs), 2024-2029
Table 46. ChemoCentryx Inc Company Summary
Table 47. ChemoCentryx Inc Atypical Chemokine Receptor 3 Product Offerings
Table 48. ChemoCentryx Inc Atypical Chemokine Receptor 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. ChemoCentryx Inc Key News & Latest Developments
Table 50. Jyant Technologies Inc Company Summary
Table 51. Jyant Technologies Inc Atypical Chemokine Receptor 3 Product Offerings
Table 52. Jyant Technologies Inc Atypical Chemokine Receptor 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Jyant Technologies Inc Key News & Latest Developments
Table 54. Polyphor Ltd Company Summary
Table 55. Polyphor Ltd Atypical Chemokine Receptor 3 Product Offerings
Table 56. Polyphor Ltd Atypical Chemokine Receptor 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Polyphor Ltd Key News & Latest Developments
Table 58. Atypical Chemokine Receptor 3 Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 59. Global Atypical Chemokine Receptor 3 Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Atypical Chemokine Receptor 3 Production by Region, 2018-2023 (K Pcs)
Table 61. Global Atypical Chemokine Receptor 3 Production by Region, 2024-2029 (K Pcs)
Table 62. Atypical Chemokine Receptor 3 Market Opportunities & Trends in Global Market
Table 63. Atypical Chemokine Receptor 3 Market Drivers in Global Market
Table 64. Atypical Chemokine Receptor 3 Market Restraints in Global Market
Table 65. Atypical Chemokine Receptor 3 Raw Materials
Table 66. Atypical Chemokine Receptor 3 Raw Materials Suppliers in Global Market
Table 67. Typical Atypical Chemokine Receptor 3 Downstream
Table 68. Atypical Chemokine Receptor 3 Downstream Clients in Global Market
Table 69. Atypical Chemokine Receptor 3 Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Atypical Chemokine Receptor 3 Segment by Type in 2022
Figure 2. Atypical Chemokine Receptor 3 Segment by Application in 2022
Figure 3. Global Atypical Chemokine Receptor 3 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Atypical Chemokine Receptor 3 Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Atypical Chemokine Receptor 3 Revenue, 2018-2029 (US$, Mn)
Figure 7. Atypical Chemokine Receptor 3 Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Atypical Chemokine Receptor 3 Revenue in 2022
Figure 9. By Type - Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 11. By Type - Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 12. By Type - Global Atypical Chemokine Receptor 3 Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 15. By Application - Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 16. By Application - Global Atypical Chemokine Receptor 3 Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 20. By Region - Global Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 21. By Country - North America Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 22. By Country - North America Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 23. US Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 28. Germany Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 29. France Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 37. China Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 41. India Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 43. By Country - South America Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 44. Brazil Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Atypical Chemokine Receptor 3 Sales Market Share, 2018-2029
Figure 48. Turkey Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Atypical Chemokine Receptor 3 Revenue, (US$, Mn), 2018-2029
Figure 52. Global Atypical Chemokine Receptor 3 Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Atypical Chemokine Receptor 3 by Region, 2022 VS 2029
Figure 54. Atypical Chemokine Receptor 3 Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 非定型ケモカイン受容体3の世界市場見通し2023年-2029年(Atypical Chemokine Receptor 3 Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • アデノシン受容体A3の世界市場見通し2023年-2029年
  • 代謝型グルタミン酸受容体1型の世界市場見通し2023年-2029年
  • アンドロゲン受容体（AR）阻害剤の世界市場見通し2023年-2029年
  • バソプレシンV1b受容体の世界市場見通し2023年-2029年
  • C5aアナフィラトキシン走化性受容体1の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆